We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+13.45%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$780M
AUM Growth
+$171M
Cap. Flow
+$112M
Cap. Flow %
14.34%
Top 10 Hldgs %
16.82%
Holding
517
New
169
Increased
169
Reduced
80
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$9.02M
2
AVGO icon
Broadcom
AVGO
+$6.42M
3
TSM icon
TSMC
TSM
+$6.34M
4
MDC
M.D.C. Holdings, Inc.
MDC
+$6.09M
5
OTEX icon
Open Text
OTEX
+$5.5M

Top Sells

Rank Stock Value
1
FOXA icon
Fox Class A
FOXA
+$9.87M
2
FANG icon
Diamondback Energy
FANG
+$9.52M
3
HD icon
Home Depot
HD
+$7.05M
4
MET icon
MetLife
MET
+$6.8M
5
ACN icon
Accenture
ACN
+$6.73M

Sector Composition

Rank Sector Weight
1 Technology 21.53%
2 Consumer Discretionary 17.87%
3 Industrials 15.32%
4 Healthcare 12.76%
5 Financials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MS icon
426
Morgan Stanley
MS
$337B
$211K 0.03%
+2,465
New +$211K
DKNG icon
427
DraftKings
DKNG
$11.4B
$208K 0.03%
+7,837
New +$181K
MCK icon
428
McKesson
MCK
$98.5B
$206K 0.03%
+483
New +$186K
VMW
429
DELISTED
VMware, Inc
VMW
$203K 0.03%
+1,416
New +$184K
EB
430
DELISTED
Eventbrite
EB
$199K 0.03%
+20,876
New +$164K
ATOM icon
431
Atomera
ATOM
$201M
$175K 0.02%
20,000
BTMD icon
432
Biote Corp
BTMD
$69.2M
$120K 0.02%
+17,689
New +$105K
SANA icon
433
Sana Biotechnology
SANA
$885M
$118K 0.02%
+19,806
New +$114K
SWIM icon
434
Latham Group
SWIM
$646M
$97K 0.01%
+26,132
New +$79.8K
MIR.WS
435
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
$50K 0.01%
27,500
PEARW
436
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$208 ﹤0.01%
188,971
-13,920
-7% -$253
AGL icon
437
Agilon Health
AGL
$1.64B
-420
Closed -$249K
AGX icon
438
Argan
AGX
$7.98B
-6,465
Closed -$262K
ALE
439
DELISTED
Allete
ALE
-11,361
Closed -$731K
CCSI icon
440
Consensus Cloud Solutions
CCSI
$669M
-8,239
Closed -$281K
CHWY icon
441
Chewy
CHWY
$8.54B
-5,605
Closed -$210K
CI icon
442
Cigna
CI
$76.6B
-16,318
Closed -$4.17M
CMC icon
443
Commercial Metals
CMC
$7.63B
-5,184
Closed -$253K
DBI icon
444
Designer Brands
DBI
$277M
-18,602
Closed -$163K
DKS icon
445
Dick's Sporting Goods
DKS
$18.4B
-2,795
Closed -$397K
DNB
446
DELISTED
Dun & Bradstreet
DNB
-97,060
Closed -$1.14M
DOL icon
447
WisdomTree True Developed International Fund
DOL
$813M
-25,850
Closed -$1.21M
DVY icon
448
iShares Select Dividend ETF
DVY
$24B
-2,325
Closed -$272K
DXLG icon
449
Destination XL Group
DXLG
$34.7M
-17,799
Closed -$98.1K
ESAB icon
450
ESAB
ESAB
$5.25B
-3,624
Closed -$214K

Similar funds

Advisory Research's Q2 2023 Portfolio in Review

As of Q2 2023, Advisory Research held 517 positions worth $780M, up 28% from $608M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Advisory Research deployed $112M of net new capital in Q2 2023, opening 169 new positions and adding to 169 existing holdings. Its largest new stake was Merck: 79,479 shares worth $9.17M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Home Depot, an estimated $7.05M trimmed.

  • Advisory Research's largest Q2 2023 buy was Merck: 79,479 shares worth $9.17M.
  • Advisory Research added most to Broadcom in Q2 2023, an estimated $6.42M increase.
  • Advisory Research's biggest Q2 2023 reduction was Home Depot, cutting an estimated $7.05M.
  • Advisory Research fully exited Fox Class A in Q2 2023, selling an estimated $9.87M.
  • Advisory Research's ten largest holdings make up 17% of its $780M portfolio in Q2 2023.
  • Advisory Research opened 169 new positions and closed 81 in Q2 2023.
  • Advisory Research's portfolio value rose 28% quarter-over-quarter to $780M.

Based on Advisory Research's 13F filing for Q2 2023, filed 14 Aug 2023.